Stiefel Laboratories, Inc.
Records under this name other than the patents Stiefel Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Stiefel Laboratories, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,875,630 | Novel Process Salts Compositions and Use Formerly held In force · High confidence | In force | High confidence | |
| US 8,449,867 | Microemulsion & sub-micron emulsion process & compositions Formerly held In force · High confidence | In force | High confidence | |
| US 7,879,867 | Crystalline antifungal compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,118,055 | Topical Anti-Pruritic Compositions and Methods of Action of Same Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,147,852 | Modified Azole Compounds as Antifungal and Antibacterial Agents Formerly held In force · Medium confidence | In force | Medium confidence | |
| US D623,519 | Jar venting disc Term ended Term ended Sep 14, 2024 · From the USPTO record | Term ended | Term ended Sep 14, 2024 | From the USPTO record |
| US 8,258,296 | Crystalline antifungal compounds Formerly held Lapsed on the fee record Ended Sep 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 4, 2024 | From the USPTO record |
| US 8,207,191 | Process, salts, composition and use Formerly held Term ended Term ended Aug 30, 2024 · From the USPTO record | Term ended | Term ended Aug 30, 2024 | From the USPTO record |
| US 8,071,133 | Oral Dosage Forms of Water Insoluble Drugs and Methods of Making the Same Lapsed on the fee record Ended Dec 6, 2023 · High confidence | Lapsed on the fee record | Ended Dec 6, 2023 | High confidence |
| US 6,699,464 | Compositions for Treatment of Hyperpigmentation and Methods for Making and Using Such Compositions Term ended Term ended Jul 30, 2022 · High confidence | Term ended | Term ended Jul 30, 2022 | High confidence |